Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE: 300158)
Health Care · Pharmaceuticals · CN
CN¥5.21
+0.58% today · -21.2% 1Y
Shanxi Zhendong Pharmaceutical Co.,Ltd (SZSE: 300158) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $770.73M and employs 3,695 people.
Over the last twelve months the share price has lost 21.2%, trading between 4.47 and 7.81.
Tweenvest scores Shanxi Zhendong Pharmaceutical Co.,Ltd across four factors: quality 64/100, value 59/100, growth 0/100. Its strongest factor is quality.
300158 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $770.73M
- Revenue (TTM)
- $356.65M
- P/E
- —
- EPS
- -0.41
- Dividend yield
- —
- Beta (5Y)
- 0.17
- 52-week high
- CN¥7.81
- 52-week low
- CN¥4.47
- Avg volume (3M)
- —
- Shares outstanding
- 992.30M
- Employees
- 3,695
- Next earnings
- —
About Shanxi Zhendong Pharmaceutical Co.,Ltd
Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research, development, production, and sales of pharmaceutical drugs in China. It offers drugs for various fields, including tumors, dermatology, digestion, urology, and cardio-cerebral drugs. The company also provides Chinese herbal medicines. Shanxi Zhendong Pharmaceutical Co.,Ltd was founded in 1995 and is based in Changzhi, China.
- ISIN
- CNE100000YR9
- Founded
- 1995
- Listed since
- Jan 7, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Luoxin Pharmaceuticals Group Stock Co., Ltd.SZSE: 002793 | $781.50M | CN¥4.82 | +3.43% |
| Supriya Lifescience LimitedNSEI: SUPRIYA | $778.24M | Rs931.00 | -5.50% |
| Center Laboratories, Inc.TPEX: 4123 | $774.75M | NT$31.20 | +0.81% |
| Sichuan Goldstone Asia Pharmaceutical Inc.SZSE: 300434 | $773.81M | CN¥12.92 | +4.11% |
| Shandong Jincheng Pharmaceutical Group Co., LtdSZSE: 300233 | $769.09M | CN¥13.60 | +2.80% |
| Shandong Keyuan Pharmaceutical Co., Ltd.SZSE: 301281 | $762.80M | CN¥47.25 | -4.20% |
| DongKook Pharmaceutical Co., Ltd.KOSDAQ: A086450 | $762.03M | ₩22,750.00 | +6.56% |
| Morepen Laboratories LimitedBSE: 500288 | $760.92M | Rs133.70 | +11.00% |
Figures last refreshed Oct 4, 2026.